Similar articles

• Framework and development of a comprehensive drug product coding system.

  DeVito CA, Aldridge GW, Wilson A, Vidis JS, Goldberg T, Dickson WM, Moore WE. DeVito CA, et al. Contemp Pharm Pract. 1979 Spring;2(2):62-5. Contemp Pharm Pract. 1979. PMID: 10316818 No abstract available.
• Drug scheduling--science and cultural perspective.

  Ray R, Dhawan A. Ray R, et al. Addiction. 2010 Jul;105(7):1151-3. doi: 10.1111/j.1360-0443.2010.02916.x. Addiction. 2010. PMID: 20642501 No abstract available.
• Study of United Kingdom product licence applications containing new active substances, 1987-9.

  Rawlins MD, Jefferys DB. Rawlins MD, et al. BMJ. 1991 Jan 26;302(6770):223-5. doi: 10.1136/bmj.302.6770.223. BMJ. 1991. PMID: 1998766 Free PMC article.
• [What rules apply here and who is responsible? How drugs are distinguished from other health care products?].

  Stephan K. Stephan K. Pharm Unserer Zeit. 2011 Jul;40(4):300-4. doi: 10.1002/pauz.201100424. Pharm Unserer Zeit. 2011. PMID: 21698627 Review. German. No abstract available.
• [A consideration from the scientific perspective. Health products: which is food, which is medicine?].

  Hahn A. Hahn A. Pharm Unserer Zeit. 2011 Jul;40(4):306-15. doi: 10.1002/pauz.201100425. Pharm Unserer Zeit. 2011. PMID: 21698629 Review. German. No abstract available.